Consecutive complex percutaneous coronary interventions using emicizumab and recombinant activated factor VII in a patient with severe haemophilia A and high-titre inhibitor.
Yu-Wei ChenWei-Jhong ChenMin-Sheng TsengHsu-Chung LoMing-Yang ShihYu-Jen ChenWen-Lieng LeeJiaan-Der WangPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)